RxDoctor Payments Data

Jill Liss, MD

Obstetrics & Gynecology · Aurora, CONPI 1205179793

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $52,488 of the $56,642 with a category attached, or 92.7%. Bayer accounts for 99.5% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $51,297, more than ten times the $40 reported in 2020. Among obstetrics & gynecology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,642in general payments, 2019–2025

Across 35 payments — averaging $1618.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$56K
  • Hologic Sales And Service, LLC$163
  • Sumitomo Pharma America, Inc.$81
  • Mayne Pharma Commercial LLC$35
$79,879in research payments, 2019–2025

Across 23 payments — averaging $3473.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sumitomo Pharma America, Inc.$80K

What the payments were for

  • Consulting fees$52,48893%
  • Travel & lodging$2,8145%
  • Food & beverage$1,3392%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$56,642 in reported general payments places this provider in the 95th percentile of 705 obstetrics & gynecology providers in Colorado.

See all obstetrics & gynecology providers in Colorado

Medicare billing

Part B allowed, 2024
$3,385
Medicare patients
15
Services billed
25

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol15$960

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →